Investors Archives - Medincell

2026 General Meeting • Live Webcast | September 30, 2026 • 6:00pm CEST | Access live

Medincell Extends Remote Voting Deadline for its Annual General Meeting Until 3:00 p.m. Today

September 30, 2026

September 30, 2026

Medincell’s Partner Teva Presented New Data on Investigational Olanzapine LAI and UZEDY® at Psych Congress 2026

September 21, 2026

Medincell to Participate in Upcoming Investor Conferences

September 9, 2026

Publication of the Notice of Meeting and Reminder of the Participation terms in the Combined General Meeting

September 8, 2026

Medincell appoints Edna Venneker, MD, as Chief Medical Officer

September 1, 2026

Medincell’s Dr Grace Kim to Participate in Piper Sandler CNS Symposium

August 11, 2026

UZEDY®: Record Q2 Net Sales of $77M, Up 43% YoY; Teva Raises 2026 Outlook

July 29, 2026

Medincell Continues to Strengthen and Renew its Board of Directors with the Proposed Appointment of Dr. Elisabeth Svanberg

July 28, 2026

Medincell Aligns Debt Maturity with Its Expected Revenue Growth Trajectory

July 15, 2026

Medincell Reports FY 2025-26 Annual Results

June 16, 2026

June 16, 2026